Angiotensin II receptor blockers and cardiovascular outcomes: The evidence now and in the future
The blood-pressure-lowering efficacy of both angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin II receptor blockers (ARBs) has been clearly demonstrated in recent years, although there is evidence that within the ARB class the individual therapies are not necessarily identical in term...
Main Author: | Michael Weber |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2001-06-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | http://jra.sagepub.com/content/2/2_suppl/12.full.pdf |
Similar Items
-
Angiotensin II receptor blockers and cardiovascular outcomes: the evidence now and in the future
by: Michael Weber
Published: (2001-06-01) -
Review: Angiotensin II receptor blockers and cardiovascular outcomes: what does the future hold?
by: Michael A Weber
Published: (2003-06-01) -
Use of angiotensin receptor blockers in cardiovascular protection. Current evidence and future directions
by: M. A. Munger
Published: (1970-01-01) -
Clinical Evidence for the Cardiovascular Benefits of Angiotensin Receptor Blockers
by: Georg Nickenig, et al.
Published: (2006-03-01) -
Clinical Evidence for the Cardiovascular Benefits of Angiotensin Receptor Blockers
by: Georg Nickenig, et al.
Published: (2006-03-01)